Matthew P. Rainka

1.0k total citations
16 papers, 870 citations indexed

About

Matthew P. Rainka is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Matthew P. Rainka has authored 16 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Matthew P. Rainka's work include Asymmetric Synthesis and Catalysis (4 papers), Cancer-related Molecular Pathways (4 papers) and Electrocatalysts for Energy Conversion (3 papers). Matthew P. Rainka is often cited by papers focused on Asymmetric Synthesis and Catalysis (4 papers), Cancer-related Molecular Pathways (4 papers) and Electrocatalysts for Energy Conversion (3 papers). Matthew P. Rainka collaborates with scholars based in United States and Israel. Matthew P. Rainka's co-authors include Stephen L. Buchwald, Jingjun Yin, X. Peter Zhang, Jennifer L. Rutherford, Jacqueline E. Milne, Yimon Aye, Andrea J. Peters, Mark D. Doherty, Peter J. Bonitatibus and Kimberly Gray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Matthew P. Rainka

16 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew P. Rainka United States	9	786	180	129	47	24	16	870
Shizue Mito United States	10	801 1.0×	179 1.0×	123 1.0×	39 0.8×	15 0.6×	26	915
Dennis Worgull Germany	15	770 1.0×	182 1.0×	155 1.2×	22 0.5×	18 0.8×	20	827
Michael J. Zacuto United States	18	856 1.1×	151 0.8×	168 1.3×	37 0.8×	24 1.0×	29	946
Gráinne C. Hargaden Ireland	10	879 1.1×	321 1.8×	141 1.1×	55 1.2×	21 0.9×	12	950
Morgan Donnard France	14	924 1.2×	148 0.8×	110 0.9×	30 0.6×	25 1.0×	44	1.0k
Boris Gášpár Switzerland	8	941 1.2×	226 1.3×	134 1.0×	39 0.8×	15 0.6×	12	1.0k
Graeme Coulthard United Kingdom	13	824 1.0×	133 0.7×	125 1.0×	53 1.1×	13 0.5×	13	908
Ramakrishna G. Bhat India	17	653 0.8×	101 0.6×	167 1.3×	30 0.6×	18 0.8×	56	720

Countries citing papers authored by Matthew P. Rainka

Since Specialization

Citations

This map shows the geographic impact of Matthew P. Rainka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew P. Rainka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew P. Rainka more than expected).

Fields of papers citing papers by Matthew P. Rainka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew P. Rainka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew P. Rainka. The network helps show where Matthew P. Rainka may publish in the future.

Co-authorship network of co-authors of Matthew P. Rainka

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew P. Rainka. A scholar is included among the top collaborators of Matthew P. Rainka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew P. Rainka. Matthew P. Rainka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Yu, Tao, Yonglian Zhang, Angela D. Kerekes, et al.. (2018). Discovery of a highly potent orally bioavailable imidazo-[1, 2-a]pyrazine Aurora inhibitor. Bioorganic & Medicinal Chemistry Letters. 28(8). 1397–1403. 4 indexed citations

2.

Perry, Robert J., et al.. (2016). Thermal Degradation of Aminosilicone Carbamates. Energy & Fuels. 30(12). 10671–10678. 2 indexed citations

3.

Bonitatibus, Peter J., et al.. (2013). Highly selective electrocatalytic dehydrogenation at low applied potential catalyzed by an Ir organometallic complex. Chemical Communications. 49(90). 10581–10581. 19 indexed citations

4.

Peters, Andrea J., et al.. (2012). Electrochemical characterization of hydrogen-bonding complexation between indoline and nitrogen containing bases. Journal of Electroanalytical Chemistry. 691. 57–65. 4 indexed citations

5.

Voss, Matthew E., Matthew P. Rainka, Mike Fleming, et al.. (2012). Synthesis and SAR studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity. Bioorganic & Medicinal Chemistry Letters. 22(10). 3544–3549. 9 indexed citations

6.

Rainka, Matthew P., Andrea J. Peters, & Grigorii L. Soloveichik. (2012). Base effects on electrochemical oxidation of indoline. International Journal of Hydrogen Energy. 38(9). 3773–3777. 4 indexed citations

7.

Driscoll, Peter, Sergio S. Rozenel, Matthew P. Rainka, et al.. (2011). Redox Catalysis for Dehydrogenation of Liquid Hydrogen Carrier Fuels for Energy Storage. ECS Meeting Abstracts. MA2011-01(42). 1948–1948. 1 indexed citations

8.

Belanger, David, Michael Williams, Patrick J. Curran, et al.. (2010). Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(22). 6739–6743. 16 indexed citations

9.

Trova, Michael P., Keith D. Barnes, Simon N. Haydar, et al.. (2009). Heterobiaryl purine derivatives as potent antiproliferative agents: Inhibitors of cyclin dependent kinases. Part II. Bioorganic & Medicinal Chemistry Letters. 19(23). 6613–6617. 14 indexed citations

10.

Herr, R. Jason, et al.. (2006). Efficient Preparation of the 18-Methoxycoronaridine Side-Chain Precursor. Synthesis. 2006(16). 2743–2747. 1 indexed citations

11.

Rainka, Matthew P., Jacqueline E. Milne, & Stephen L. Buchwald. (2005). Dynamic Kinetic Resolution of α,β‐Unsaturated Lactones through Asymmetric Copper‐Catalyzed Conjugate Reduction: Application to the Total Synthesis of Eupomatilone‐3. Angewandte Chemie International Edition. 44(38). 6177–6180. 66 indexed citations

12.

Rainka, Matthew P., et al.. (2005). Dynamic Kinetic Resolution in Cu-Catalyzed Conjugate Hydride Addition. Synfacts. 2006(1). 34–34. 1 indexed citations

13.

Rainka, Matthew P., Jacqueline E. Milne, & Stephen L. Buchwald. (2005). Dynamic Kinetic Resolution of α,β‐Unsaturated Lactones through Asymmetric Copper‐Catalyzed Conjugate Reduction: Application to the Total Synthesis of Eupomatilone‐3. Angewandte Chemie. 117(38). 6333–6336. 59 indexed citations

14.

Rainka, Matthew P., Yimon Aye, & Stephen L. Buchwald. (2004). Copper-catalyzed asymmetric conjugate reduction as a route to novel β-azaheterocyclic acid derivatives. Proceedings of the National Academy of Sciences. 101(16). 5821–5823. 85 indexed citations

15.

Rutherford, Jennifer L., Matthew P. Rainka, & Stephen L. Buchwald. (2002). An Annulative Approach to Highly Substituted Indoles: Unusual Effect of Phenolic Additives on the Success of the Arylation of Ketone Enolates. Journal of the American Chemical Society. 124(51). 15168–15169. 158 indexed citations

16.

Yin, Jingjun, Matthew P. Rainka, X. Peter Zhang, & Stephen L. Buchwald. (2002). A Highly Active Suzuki Catalyst for the Synthesis of Sterically Hindered Biaryls: Novel Ligand Coordination. Journal of the American Chemical Society. 124(7). 1162–1163. 427 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact